Jump to content

Page values for "Bupropion"

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringBupropion
brandStringWellbutrin (IR, SR, XL), Zyban (smoking cessation), Aplenzin (hydrobromide salt), Forfivo XL
structureFile
classesList of String, delimiter: ,[[:Category:NDRIs|Norepinephrine-dopamine reuptake inhibitor (NDRI)]] [[:Category:Antidepressants|Antidepressant]] [[:Category:Smoking cessation medicines|Smoking cessation medicine]]
mechanismString
usesString'"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"'
starting_doseStringSR 150 mg PO once daily for 3 days, then 150 mg BID. XL 150 mg PO once daily for 4 days, then 300 mg once daily. Zyban (smoking cessation) 150 mg daily for 3 days, then 150 mg BID
preparationsStringSR tablets 100, 150, 200 mg; XL tablets 150, 300 mg; IR tablets 75, 100 mg (less common); Aplenzin (bupropion hydrobromide) 174, 348, 522 mg
fda_maxString450 mg/day; doses above this raise seizure risk steeply
pill_idText
routesList of String, delimiter: ,Oral
onsetString1-2 weeks for antidepressant effect; smoking-cessation effect builds over the first 1-2 weeks
durationStringSR ~12 hours; XL 24 hours
halflifeStringBupropion ~21 hours; hydroxybupropion (active metabolite) ~20-37 hours'"`UNIQ--ref-00000023-QINU`"'
bioavailabilityString~5-20% (extensive first-pass), highly variable between individuals'"`UNIQ--ref-00000024-QINU`"'
pregnancyStringLimited human data; some animal cardiac signal not clearly replicated in human cohort studies; observational signals inconclusive.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries the antidepressant '''Boxed Warning''' for suicidality in children, adolescents, and young adults. Not controlled'"`UNIQ--ref-00000025-QINU`"'